Inovio Pharmaceuticals (INO) Ownership - Who owns Inovio Pharmaceuticals?

Industry: @Medical Specialties

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Profile

Industry

Medical Specialties

Address

660 West Germantown Pike

Phone

+1 267 440-4200

Employees

122

Web

https://www.inovio.com

Details

Group

Domestic Stock Funds

Fundamentals

INO

Capitalization

163M

P/E Ratio

N/A

Risk (Beta)

1.89

Dividend Yield

N/A

Total Cash

110M

Total Cash/Share

4.25

Total Debt

13M

Total Debt/Equity

N/A

Projected Growth (PEG Ratio)

N/A

Revenue/Share (as % of the share price)

0.02%

Revenue

592K

ROE

N/A

Book Value

96.7M

P/B Ratio

1.69

Cash Flow

N/A

Earnings

-5.07

Average Daily Volume YTD

N/A

Common Shares Outstanding - Security Level

26K

Current Ratio

4.45

Current Revenue Per Employee

825.92

Dividends Per Share - Security

N/A

EBITDA

-118.07M

Float

N/A

Float - Current

N/A

Gross Income Margin

100.00

Revenue To Assets

-66.32

Shares Held By Institutions

88.5M

Shares Outstanding - Current

26M

Total Liabilities

37.1M

Total Volume MTD

N/A

Value

N/A

Gain YTD

6.209

View a ticker or compare two or three

Compare

INO

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For INO
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for INO (Try 14 days for $1 only)

A.I. Advisor

published General Information

General Information

a developer of synthetic vaccines and immune therapies for cancers and infectious diseases

Industry Biotechnology